AstraZeneca's operating profit 2006-2023
This statistic shows the reported operating profit of pharmaceutical company AstraZeneca from 2006 to 2023. AstraZeneca plc is one of the top 10 pharmaceutical companies worldwide (based on Rx drug revenue). The multinational company is headquartered in London, UK. AstraZeneca is focused on products for following major disease areas: cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation. In 2023, the company reported an operating profit of some 8.2 billion U.S. dollars, the highest since 2011. Together with the Oxford University, the AstraZeneca also developed one of the first effective COVID-19 vaccines.